Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi.

Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ, Ranganathan SC, Waters VJ, Ratjen FA.

Ann Am Thorac Soc. 2014 Oct;11(8):1298-306. doi: 10.1513/AnnalsATS.201405-203AS. Review.

2.

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.

Waters V, Ratjen F.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD010004. doi: 10.1002/14651858.CD010004.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;12:CD010004.

PMID:
23235684
3.

Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.

Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ, Ranganathan SC, Waters VJ, Ratjen FA.

Ann Am Thorac Soc. 2014 Sep;11(7):1120-9. doi: 10.1513/AnnalsATS.201402-050AS. Review.

4.

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.

Waters V, Ratjen F.

Cochrane Database Syst Rev. 2016 Dec 19;12:CD010004. doi: 10.1002/14651858.CD010004.pub4. Review.

5.

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.

Waters V, Ratjen F.

Cochrane Database Syst Rev. 2014 Dec 3;(12):CD010004. doi: 10.1002/14651858.CD010004.pub3. Review. Update in: Cochrane Database Syst Rev. 2016 Dec 19;12 :CD010004.

PMID:
25470304
6.
7.

[Mycobacterial lung disease in patients with cystic fibrosis--report of three cases].

Wyrostkiewicz D, Skorupa W, Jakubowska L, Zabost A, Kuś J.

Pneumonol Alergol Pol. 2014;82(6):561-7. doi: 10.5603/PiAP.2014.0074. Polish.

8.

Nontuberculous Mycobacterial Infections in Cystic Fibrosis.

Martiniano SL, Nick JA, Daley CL.

Clin Chest Med. 2016 Mar;37(1):83-96. doi: 10.1016/j.ccm.2015.11.001. Epub 2015 Dec 23. Review.

PMID:
26857770
9.

Nontuberculous mycobacterial infections in cystic fibrosis.

Martiniano SL, Nick JA.

Clin Chest Med. 2015 Mar;36(1):101-15. doi: 10.1016/j.ccm.2014.11.003. Review.

PMID:
25676523
10.

Nontuberculous mycobacteria in patients with cystic fibrosis.

Leung JM, Olivier KN.

Semin Respir Crit Care Med. 2013 Feb;34(1):124-34. doi: 10.1055/s-0033-1333574. Epub 2013 Mar 4. Review.

PMID:
23460012
11.

Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.

Worlitzsch D, Rintelen C, Böhm K, Wollschläger B, Merkel N, Borneff-Lipp M, Döring G.

Clin Microbiol Infect. 2009 May;15(5):454-60. doi: 10.1111/j.1469-0691.2008.02659.x. Epub 2009 Jan 22.

12.

The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.

Green H, Jones AM.

Semin Respir Crit Care Med. 2015 Apr;36(2):225-35. doi: 10.1055/s-0035-1546752. Epub 2015 Mar 31. Review.

PMID:
25826590
13.

Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.

Schwartz M, Fisher S, Story-Roller E, Lamichhane G, Parrish N.

Microb Drug Resist. 2018 Oct;24(8):1191-1197. doi: 10.1089/mdr.2017.0286. Epub 2018 Jan 25.

14.

Increasing nontuberculous mycobacteria infection in cystic fibrosis.

Bar-On O, Mussaffi H, Mei-Zahav M, Prais D, Steuer G, Stafler P, Hananya S, Blau H.

J Cyst Fibros. 2015 Jan;14(1):53-62. doi: 10.1016/j.jcf.2014.05.008. Epub 2014 Jun 7.

15.

Pathophysiology and management of pulmonary infections in cystic fibrosis.

Gibson RL, Burns JL, Ramsey BW.

Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51. Review.

PMID:
14555458
16.

Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: the Mycobacterium abscessus model.

Le Moigne V, Rottman M, Goulard C, Barteau B, Poncin I, Soismier N, Canaan S, Pitard B, Gaillard JL, Herrmann JL.

Vaccine. 2015 Apr 27;33(18):2118-24. doi: 10.1016/j.vaccine.2015.03.030. Epub 2015 Mar 21.

PMID:
25804706
17.

Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.

Coolen N, Morand P, Martin C, Hubert D, Kanaan R, Chapron J, Honoré I, Dusser D, Audureau E, Veziris N, Burgel PR.

J Cyst Fibros. 2015 Sep;14(5):594-9. doi: 10.1016/j.jcf.2015.02.006. Epub 2015 Feb 28.

18.

[Pulmonary Mycobacterium abscessus sensu lato infection in patients without cystic fibrosis].

Payet A, Héry-Arnaud G, Ansart S, Barnier A, Quinio D, Fangous MS, Leroyer C, Couturaud F.

Rev Mal Respir. 2016 Mar;33(3):253-6. doi: 10.1016/j.rmr.2015.06.013. Epub 2015 Aug 1. French.

PMID:
26238926
19.

Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.

Qvist T, Pressler T, Høiby N, Katzenstein TL.

Respir Res. 2014 Apr 11;15:41. doi: 10.1186/1465-9921-15-41.

20.

Nontuberculous Mycobacterial Infections in Cystic Fibrosis.

Martiniano SL, Nick JA, Daley CL.

Thorac Surg Clin. 2019 Feb;29(1):95-108. doi: 10.1016/j.thorsurg.2018.09.008. Review.

PMID:
30454926

Supplemental Content

Support Center